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Abstract
Following our recent report that phagocytic cells (neutrophils, PMNs, and macrophages) are newly discovered sources of
catecholamines, we now show that both epinephrine and norepinephrine directly activate NFkB in macrophages, causing
enhanced release of proinflammatory cytokines (TNFa, IL-1b, IL-6). Both adrenal-intact (AD+) and adrenalectomized (ADX)
rodents were used, because ADX animals had greatly enhanced catecholamine release from phagocytes, facilitating our
efforts to understand the role of catecholamines released from phagocytes. Phagocytes isolated from adrenalectomized rats
displayed enhanced expression of tyrosine-hydroxylase and dopamine-b-hydroxylase, two key enzymes for catecholamine
production and exhibited higher baseline secretion of norepinephrine and epinephrine. The effects of upregulation of
phagocyte-derived catecholamines were investigated in two models of acute lung injury (ALI). Increased levels of
phagocyte-derived catecholamines were associated with intensification of the acute inflammatory response, as assessed by
increased plasma leak of albumin, enhanced myeloperoxidase content in lungs, augmented levels of proinflammatory
mediators in bronchoalveolar lavage fluids, and elevated expression of pulmonary ICAM-1 and VCAM-1. In
adrenalectomized rats, development of ALI was enhanced and related to a2-adrenoceptors engagement but not to
involvement of mineralocorticoid or glucocorticoid receptors. Collectively, these data demonstrate that catecholamines are
potent inflammatory activators of macrophages, upregulating NFkB and further downstream cytokine production of these
cells. In adrenalectomized animals, which have been used to further assess the role of catecholamines, there appears to be a
compensatory increase in catecholamine generating enzymes and catecholamines in macrophages, resulting in
amplification of the acute inflammatory response via engagement of a2-adrenoceptors.
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Introduction
During an immune response, the central nervous system and the
immune system communicate with each other [1]. The major
pathway systems involved in this cross-talk are the hypothalamic-
pituitary-adrenal (HPA) axis and the autonomic nervous system
[1–3]. Activation of the vagus-dominated parasympathetic,
cholinergic nervous system is known to greatly attenuate and
dampen the inflammatory response via nicotinergic cholinergic
receptors expressed on macrophages and other immune cells [4,5].
According to its afferent and efferent arms, this effect has been
termed ‘‘inflammatory reflex’’ [2] or ‘‘cholinergic anti-inflamma-
tory pathway’’ [6]. In contrast, the role of the sympathetic nervous
system (SNS) during inflammation seems to be more complex and
less well understood. On the one hand, SNS activation seems to
target immune cells that express adrenoreceptors, exacerbating the
local inflammatory response [7,8], and increase the general
immune and proinflammatory mediator response [9–11]. On
the other hand, several studies indicate an inhibitory effect of the
SNS on the inflammatory response, suppressing the immune
response by decreasing the activity of natural killer cells and T cell
immunity [12–15]. In addition, catecholamines released from
presynaptic sympathetic nerve terminals lead to localized vaso-
constriction, preventing invading pathogens from becoming
systemic [3].
Over two decades ago, lymphocytes were described as sources
of catecholamines [16]. These lymphocyte-derived catecholamines
seem to act in an autocrine/paracrine fashion that affects
lymphocyte trafficking [17], vascular perfusion, cell proliferation
[18], cytokine production and the functional activity of lympho-
cytes [19,20]. Recently, phagocytes (macrophages and neutrophils)
have also been identified as a newly recognized source of
catecholamines that exert a similar autocrine/paracrine regulation
of phagocytes following release of norepinephrine or epinephrine
[8,20–22]. Additional experiments demonstrated that blockade of
these phagocyte-derived catecholamines (by pharmacological
blockade of catecholamine generating enzymes or blockade of
adrenoceptors) greatly attenuated lung inflammatory injury, while
the opposite was the case when the catecholamine-inactivating
enzymes catechol-O-methyltransferase (COMT) and monoamine
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adrenergic system during an inflammatory response may greatly
enhance the local inflammatory response, resulting in neutrophil
accumulation [23] and enhanced cytokine production. In the
current study, we sought to further define the role of phagocyte-
derived catecholamines on inflammation on a molecular level and
in a setting of acute inflammatory, single organ injury.
Results
Catecholamines Induce NFkB Activation and Release of
Cytokines in Mouse Macrophages
Following isolation, peritoneal mouse macrophages were
stimulated with a range of concentrations of norepinephrine or
epinephrine (10
212–10
26 M) for 30 min at 37uC. While unstimu-
lated macrophages exhibited low levels of NFkB activation,
significant NFkB activation occurred in a dose-dependent manner,
peaking at the 10
210 M dose of catecholamine (Figure 1A, B). In
parallel, a dose-dependent decrease of IkBa levels in cytosolic
fractions of macrophages (Figure 1C, D) was found following
exposure to norepinephrine or epinephrine. Similar results were
obtained with mouse neutrophils (data not shown).
This suggests induction of intracellular proinflammatory
pathways by norepinephrine and epinephrine. To evaluate if this
catecholamine-induced activation of NFkB was followed by
increased downstream production of proinflammatory cytokines,
peritoneal mouse macrophages were incubated for 4 hrs at 37uC
with either HBSS (negative control), LPS (positive control, 20 ng/
ml), or various doses of norepinephrine or epinephrine that lead to
NFkB activation (10
211–10
28 M). The cell supernatant fluids
were evaluated for TNFa, IL-1b and IL-6 and MIP-2 by ELISA.
Exposure to norepinephrine or epinephrine not only induced
activation of NFkB (Figure 1), but caused release of TNFa, IL-1b
and IL-6 and MIP-2 from isolated macrophages in a dose
dependent manner (Figures 2 and 3). Interestingly, 10
210 M
norepinephrine or epinephrine alone caused $50% of the
amounts of released cytokines when compared to macrophages
incubated with LPS (20 ng/ml).
Increased Baseline-Expression of Catecholamine-
generating Enzymes and Upregulation of Catecholamine
Secretion in Phagocytes obtained from
Adrenalectomized (ADX) Animals
We have recently identified phagocytes as a newly recognized
source of norepinephrine and epinephrine [8]. To investigate the
inflammatory potential of phagocyte-derived catecholamines, we
isolated both blood neutrophils and alveolar macrophages from
otherwise healthy and untreated adrenal-intact (AD+) and
adrenalectomized (ADX) rats. When mRNA was obtained from
isolated, unstimulated cells, phagocytes from ADX animals
expressed higher baseline levels for the two key enzymes involved
in catecholamine synthesis, tyrosine-hydroxylase (TH) and dopa-
mine-b-hydroxylase (DBH) (Figure 4A, B), as demonstrated by
real-time PCR. In parallel, the basal secretion (after 15 min in
culture) of norepinephrine and epinephrine from isolated and
otherwise untreated blood neutrophils and alveolar macrophages
Figure 1. Isolated peritoneal mouse macrophages (A, B) were exposed to various concentrations of norepinephrine or epinephrine
for 30 min at 37uC. Then, nuclear proteins were extracted from 10610
6 cells protein concentrations adjusted and NFkB p65 activation assessed.
Each bar represents n=4. In a second set of experiments, following incubation with various concentrations of norepinephrine or epinephrine
(30 min, 37uC), peritoneal mouse macrophages (5610
6/ml; C, D) were lysed and cytosol subjected to Western blotting analysis for IkBa. Depicted
blots are representative of 3 independent experiments. Neg ctrl, incubation with HBSS.
doi:10.1371/journal.pone.0004414.g001
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animals when compared to cells from AD+ animals (Figure 4C,
D). This may represent a compensatory response in order to
maintain intrinsic catecholamine levels in the absence of adrenal
glands.
Adrenalectomized Animals Display Elevated Baseline
Levels in Plasma of Proinflammatory Mediators
To investigate whether the increased phagocytic baseline
production of catecholamines in ADX rats (Figure 4) would result
in activation of NFkB (Figure 1) with subsequent release of TNFa,
IL-1b and IL-6 and MIP-2 by macrophages (Figures 2 and 3) in
vivo, plasma from healthy and otherwise untreated AD+ or ADX
animals was obtained and screened for baseline levels of
proinflammatory mediators. As shown in Table 1, ADX animals
displayed but statistically significant increase in plasma levels of the
proinflammatory cytokines (TNFa, IL-1b and IL-6), as well as the
inflammatory chemokine, CINC-1, when compared to AD+
littermates.
Adrenalectomy Exacerbates Acute Lung Injury
Figures 5 and 6 display data obtained in the immune complex-
induced ALI model. As shown in Figure 5, adrenalectomized
(ADX) rats showed a greatly enhanced intensity of the acute
inflammatory response. The permeability index (an indicator of
vascular leakage of albumin) increased nearly 3 fold in ADX rats
(Figure 5A) when compared to AD+ rats. Myeloperoxidase (MPO)
content in lung homogenates increased nearly 50% in ADX rats
(Figure 5B), and bronchoalveolar lavage (BAL) fluids had a higher
leukocyte content (by nearly 2 fold), due to increased content of
PMNs which accounted for .95% of BAL leukocytes (Figure 5C).
The intensified level of injury was also apparent in morphological
changes in lungs (Figure 5, frames D–I). While ADX and adrenal-
intact rats exhibited comparable features in control (uninjured)
lungs (Figure 5D, G), ADX animals had clearly increased evidence
of injury as reflected in intensified number of PMNs, fibrin and
hemorrhage in the interstitial and alveolar compartments
(Figure 3H, I) when compared to lungs from adrenal intact rats
(Figure 5E, F).
Figure 2. Isolated peritoneal mouse macrophages were exposed to various concentrations of norepinephrine (10
211–10
28 M) or
LPS (20 ng/ml, positive control) for 30 min at 37uC. Then, supernatant fluids were obtained and subjected to ELISA analysis for TNF-a (A), IL-1b
(B), IL-6 (C) and MIP-2 (D). Each bar represents n=4–7. Neg ctrl, incubation with HBSS.
doi:10.1371/journal.pone.0004414.g002
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fluid analysis from adrenal-intact and ADX rats, which consis-
tently showed significantly increased levels of proinflammatory
cytokines (IL-6, TNFa and IL-1b) (Figure 6A–C) in ADX animals.
In parallel, the levels of norepinephrine in BAL fluids from injured
lungs were significantly elevated in ADX animals when compared
to adrenal-intact littermates (Figure 6D). As demonstrated by
Western blots in lung homogenates, the adhesion molecules
ICAM-1 and VCAM-1 were modestly and significantly upregu-
lated during lung injury (Figure 6, lower frames E, F). ADX
animals had higher levels of these cell adhesion molecules than
their adrenal-intact littermates. Finally, as expected, ADX rats
showed evidence suggesting enhanced activation of NFkB in lung
homogenates as assessed by EMSA (data not shown).
To exclude that these results were unique to immune complex-
induced ALI, lung injury was also induced in rats by intra-tracheal
administration ofLPSand subjectedtoanalysisforvascularleakage,
MPO content, BAL fluid cytokines measurements and histological
analysis. The results, as shown in Figure 7, paralleled the pattern
found in IC-induced lung injury, indicating amplified injury in
ADX rats as defined by increased albumin leakage (frame A),
elevated MPO content (frame B), amplified cytokine levels in BAL
fluids (frames C–E) and enhanced histopathology of inflammation
(neutrophils, fibrin) and injury (hemorrhage) (frames F–I).
The a2-adrenergic Receptor Mediates the Severity of
Acute Lung Injury in ADX Rats
Recently, we have described a central role for a2-adrenoceptor
in the pathophysiology of experimental acute lung injury [8].
Pharmacological a2-adrenoceptor blockade by RX821002 greatly
reduced the intensity of ALI, while blockade of all other
adrenoceptors failed to change the intensity of lung injury [8].
To determine if a2-adrenoceptors or rather the absence of
mineralocorticoids and glucocorticoids might account for the
increased level of inflammatory lung injury in ADX rats, we
administered the specific a2-adrenoceptor blocker, (RX 821002),
or the competitive aldosterone receptor antagonist (spironolactone)
in adrenal-intact and adrenalectomized animals immediately after
induction of IC-ALI. The glucocorticoid receptor antagonist, RU
28362, was administered 1 hr before initiation of lung injury. As
shown in Figure 8, blockade of the a2-adrenergic receptor
significantly reduced by 70% (p,0.01) the intensity of the albumin
leak into lungs of ADX rats. In AD+ animals, blockade of the a2-
adrenoceptor reduced the albumin leak following ALI by ,46%,
Figure 3. Following isolation, peritoneal mouse macrophages incubated to HBSS (negative conrol), LPS (20 ng/ml, positive control)
or 10
211–10
28 M epinephrine (30 min, 37uC). Obtained supernatants were analyzed for TNF-a (A), IL-1b (B), IL-6 (C) and MIP-2 (D) using ELISA
measurements. n=4–7 per experimental group.
doi:10.1371/journal.pone.0004414.g003
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corticoid receptor blockade (by RU 28362 and spironolactone,
respectively) neither exacerbated nor reduced the level of injury in
both adrenal-intact or ADX animals (Figure 8), suggesting that it is
adrenergic receptor engagement rather than cortical mineralocor-
ticoid or glucocorticoid receptor engagement that affects the
inflammatory response in ADX animals.
Discussion
There is increasing evidence that the immune system and the
central nervous system (CNS) interact to modulate each other via
autonomic pathways [2–5]. Immune mediators and cytokines
released by the innate immune system rapidly activate neuronal
responses, resulting in amplified local immune responses designed
to clear pathogens and triggering regional neural and systemic
neuroendocrine responses, (including local catecholamine produc-
tion and systemic glucocorticoid release), both of which seek to
return the system to a homeostatic state [1].
Following interaction with adrenergic receptors, the physiolog-
ical actions of catecholamines can be terminated by cellular
reuptake, followed by their intracellular inactivation by mono-
amine oxidase (MAO) or catechol-O-methyltransferase (COMT).
Moreover, there is now evidence for the presence of dopamine and
norepinephrine transporters (DAT and NAT, respectively) on
lymphocytes, which facilitate the rapid local removal of dopamine
or norepinephrine by reuptake [24–27]. Similarly, catecholamine-
specific transporters have been described on nuclear membranes
of lymphocytes, which actively transport catecholamines from the
cytoplasm into the cell nucleus, where catecholamines can interact
with nuclear receptors and regulate proliferation or apoptosis [28–
Figure 4. Rat blood neutrophils and rat alveolar macrophages were obtained from AD+ and ADX animals and mRNA isolated and
subjected to real-time PCR analysis for both key-enzymes of catecholamine synthesis, tyrosine-hydroxylase (rate limiting step) and
dopamine-b-hydroxylase (final conversion step) (A, B). Following 15 min culture of unstimulated phagocytes derived from AD+ and ADX
animals, supernatant fluids were analyzed for norepinephrine (C) and epinephrine (D) by ELISA. Each bar n=5.
doi:10.1371/journal.pone.0004414.g004
Table 1. Plasma Baseline Levels of Proinflammatory
Mediators (pg/ml).
Mediators AD+ ADX
TNFa 26613 4 62*
IL-1b 44646 1 62*
IL-6 105641 2 8 61*
CINC-1 23612 7 61*
For each sample, n=8–10.
Data are expressed as mean6SEM.
*=p,0.01 vs. AD+.
doi:10.1371/journal.pone.0004414.t001
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COMT do not enter the nucleus, it remains to be determined
how and by which mechanism intranuclear actions of catechol-
amines are terminated. In the present study we describe in
macrophages a catecholamine-induced, dose dependent activation
of NFkB p65 and a decrease of cytosolic IkBa (Figure 1). A similar
pattern has been described when alveolar macrophages were
exposed in vitro to IgG immune complexes [32]. Thus, catechol-
amines enhance cytokine release by macrophages (Figures 2 and 3)
via activation and translocation of NFkB (Figure 1), indicating that
catecholamines are powerful cellular hormones that self-regulate
the activation level and the inflammatory potential of inflamma-
tory cells.
It is well established that phagocytes (PMNs and alveolar
macrophages) are essential for initiation of acute lung injury in our
present models [33–36]. These cells are known to express all
adrenergic receptors (both a and b subtypes) and to produce
enhanced levels of TNFa in the presence of an a2-adrenergic
agonist [8,19,20]. Accordingly, in the present study, the mecha-
nism of augmented injury in ADX rodents might be related to an
elevated production of phagocyte-derived catecholamines in an
attempt to restore systemic catecholamine levels in the absence of
the adrenal glands, resulting in increased catecholamine produc-
tion by PMNs and macrophages, as suggested in Figure 4. This
seems to be followed by direct activation of NFkB and ‘‘priming’’
of macrophages, leading to an increased baseline production of
proinflammatory mediators (Figures 1–3 and Table 1). Upon a
‘‘second hit’’, such as exposure to LPS, IgG-IC or other
inflammatory stimuli, the inflammatory response is greatly
accentuated. Another possibility might be a compensatory over-
activity of pulmonary sympathetic nerve endings or increased
catecholamine production by lymphocytes, resulting in increased
norepinephrine levels in BAL fluids. However, we recently
demonstrated in the present model of ALI that neither T cells
nor sympathetic nerves (by cell depletion or chemical sympathec-
tomy, respectively) are involved in events leading to ALI, but,
rather, alveolar macrophages and neutrophils are responsible for
increased catecholamine levels in BAL fluids following IC-ALI [8].
Moreover, in a recent study, untreated and healthy bilaterally
adrenalectomized rats displayed morphological signs of renal
inflammation when compared to untreated adrenal-intact litter-
mates [37], confirming our findings that adrenalectomized rats
exhibit a certain proinflammatory priming. Thus, it is now
becoming evident, that the sympathetic nervous system may play a
Figure 5. IgG immune complex (IC)-induced lung injury was induced in adrenal-intact (AD+) and adrenalectomized (ADX) rats.
Vascular leakage (A), content of myeloperoxidase in lung extracts (B) and total white cell content in BAL fluids (C) were assessed. In negative
controls, intratracheal administration of anti-BSA was replaced by PBS. Lungs were surgically removed 4 hr after intrapulmonary deposition of IgG
immune complexes, tissues fixed in buffered 5% formaldehyde, and paraffin-embedded lung sections were stained with hematoxylin and eosin (D–I).
Frames D–F, histology of lungs from adrenal-intact animals; frames G–I represent lungs from adrenalectomized littermates. Sections are
representative for at least three rats per group. For each bar n.5 rats.
doi:10.1371/journal.pone.0004414.g005
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thought. While it clearly has profound anti-inflammatory effects
during systemic inflammation as described above [1,3], we are now
beginning to understand that the local inflammatory response can
be immensely boosted through local, cell-dervied catecholamine
production and subsequent adrenergic signaling in various
immune cells [7,8].
Further hormonal key players antagonizing inflammation are
glucocorticoids, which are rapidly released from the adrenal cortex
following activation of the HPA axis and down-regulate
inflammation [38]. It was somewhat surprising that greatly
increased levels of ALI occurred in ADX rats and that this was
not related to engagement of mineralocorticoid or glucocorticoid
receptors (Figure 8). Glucocorticoids ultimately inhibit transcrip-
tion, which takes up to several hours, whereas lung injury in the
current model peaks 4 or 6 hr after initiation. Thus, it seems
unlikely that various glucocorticoid effects could have been fully
developed in this short period of time. Moreover, rats possess the
ability to synthesize steroids in non-adrenal tissues. The rat CNS
has been identified as a source of 11b-hydroxylase and aldosterone
synthase [22,39,40]. Other non-adrenal sources include the kidney
and vascular tissues [40]. Thus, it seems likely that, in the absence
of the adrenal glands, these extra-adrenal sources of corticosterone
and aldosterone compensate for the lack of the adrenal medulla in
an attempt to maintain systemic levels of corticoids.
This study suggests that catecholamines activate macrophage
NFkB with subsequent cytokine production in a dose dependent
manner. Upregulation of phagocyte-derived catecholamines (by
adrenalectomy) results in intensification of the acute inflammatory
response.
Materials and Methods
Reagents
Norepinephrine and epinephrine were obtained from Sigma-
Aldrich (St. Louis, MO) and were of highest purity. These
chemical compounds were synthetically manufactured under
sterile conditions and were thus virtually free of endotoxin, RNA
or DNA according to the manufacturer.
Animals and Anaesthesia
All investigative procedures and the animal facilities conformed
to the Guide of Care and Use of Laboratory Animals published by
the US National Institutes of Health. The study was approved by
the University Animal Care and Use Committee (UCUCA) and
performed according to appropriate guidelines. Specific pathogen-
Figure 6. BAL fluids 4 hr after immune complex-induced lung injury, showing content of interleukin-6 (IL-6) (A), tumor necrosis
factor a (TNFa) (B), interleukin-1b (IL-1b) (C) and norepinephrine (D). Four hours after induction of injury, whole lungs were flushed,
surgically removed, homogenized and subjected to Western blot analysis for the adhesion molecules ICAM-1 (E) and VCAM-1 (F). For Western blot
studies, experiments were repeated, using 5 different samples per group. Blots shown are of representative bands. For each bar n$5 rats.
Abbreviations: neg ctrl, negative control; AD+, adrenal-intact animals; ADX, adrenalectomized animals; IC-ALI, immune complex-induced acute lung
injury.
doi:10.1371/journal.pone.0004414.g006
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were used for data displayed in Figure 1 and Table 1.
Adrenalectomized Long-Evans rats (300–325 g) were obtained
from Taconic, Hudson, NY. Un-manipulated, adrenal-intact
littermates (300–325 g; Taconic, Hudson, NY) served as controls.
Isolation of mouse macrophages
Peritoneal mouse macrophages were obtained using the
thioglycollate method. Mice were injected with 1.5 ml of 2.4%
thioglycollate in ddH2O. Four days later, transmigrated macro-
phages were harvested by instillation and aspiration of 8 ml PBS
(Gibco, Grand Island, NY). Cells were then spun down and
subjected to an additional washing step using PBS. Macrophages
were then resuspended in HBSS (with Ca
2+/Mg
2+). The obtained
cell suspension was of high purity, as determined by optical cell
differential counts (neutrophils: 0%, macrophages: 97%, lympho-
cytes: 1%, eosinophils: 2%). Mouse macrophages were exclusively
used for the experiments in Figures 1 through 3, since high cell
numbers were needed for these experiments in order to obtain
adequate numbers of nuclei. For all other experiments, rat
phagocytes were used.
Isolation of rat neutrophils and macrophages
For rat neutrophil isolation, whole blood samples were drawn
from the inferior vena cava into syringes containing anticoagulant
ACD (Baxter Health Care, Deerfield, IL, USA) (0.1 ml/ml blood).
Cells were isolated by using Ficoll-Paque gradient centrifugation
(Pharmacia Biotech AB, Uppsala, Sweden) followed by a dextran
sedimentation step. After hypotonic lysis of residual blood cells,
neutrophils were resuspended in HBSS. The purity of this
neutrophil suspension was .95%. Alveolar macrophages were
obtained by bronchioalveolar lavage of rats by instilling and
withdrawing 10 ml sterile Dulbecco’s PBS (without Ca
2+/Mg
2+)
three times from the lungs via an intratracheal cannula. Cells were
then spun down and resuspended in HBSS. The purity of the cell
suspension was .95%, with the rest of the cells being lymphocytes.
Figure 7. ALI was induced by airway instillation of LPS (300 mg). In parallel to immune complex-induced ALI, vascular leakage (A) and
myeloperoxidase (MPO) activity in lung extracts (B) 6 hr after initiation of injury were measured. Bronchioalveolar lavage fluids obtained 6 hr after
introduction of LPS-induced lung injury were assessed for content of IL-6 (C), TNFa (D), and IL-1b (E). Following surgical removal 6 hr after
intrapulmonary LPS deposition, lungs were formalin-fixed, paraffin-embedded and stained with hematoxylin and eosin (F–I). Insets F and G show
lungs of adrenal-intact animals, while lungs of rats lacking their adrenal glands are presented in insets H and I. For each bar n.5 rats. Abbreviations
used: neg ctrl, negative control; AD+, adrenal-intact animals; ADX, adrenalectomized animals; LPS-ALI, LPS-induced acute lung injury.
doi:10.1371/journal.pone.0004414.g007
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Isolated mouse neutrophils were adjusted to 10610
6/ml and
resuspended in RPMI medium containing 0.5% BSA (Sigma-
Aldrich, St. Louis, MO). Cells were then allowed to settle down for
2 hrs at 37uC/5%CO2 to discard non-adherent and non-viable
cells. Upon stimulation with various doses of norepinephrine or
epinephrine (10
212–10
26 M; both Sigma-Aldrich, St. Louis, MO)
for 30 min at 37uC/5%CO2, nuclear extracts were obtained using
a commercially available kit (‘‘Nuclear Extract Kit’’, Active Motif,
Carlsbad, CA) according to the manufacturer’s instructions,
quantified by BCA
TM protein measurement (Thermo Scientific,
Rockford, IL), protein adjusted and stored at 280uC until further
analysis. NFkB p65 activation was assessed with an ELISA kit
(‘‘TransAM
TM NFkB p65’’, Active Motif, Carlsbad, CA) accord-
ing to the manufacturer’s instructions. Recombinant NFkB p65
protein (Active Motif, Carlsbad, CA) was used to generate the
standard curve.
Western Blot analysis for IkBa
Following isolation and incubation with various concentrations
of norepinephrine or epinephrine (30 min, 37uC), peritoneal
mouse neutrophils (5610
6/ml) were lysed and cytosol was
subjected to Western Blotting analysis for IkBa. Samples were
separated in a denaturing polyacrylamide gel and transferred to a
PVDF membrane. After blocking with 5% milk-TBST washing in
TBST, membranes were then incubated in the appropriate
primary antibodies (IkBa or GAPDH; both from Abcam,
Cambridge, MA) at 4uC overnight. After washing, membranes
were incubated with the appropriate HRP-conjugated secondary
antibodies (Amersham, Arlington Heights, IL) and analyzed by
ECL development. Neg ctrl, incubation with HBSS.
Cytokine-production by neutrophils following
norepinephrine and epinephrine incubation
Isolated mouse neutrophils were adjusted to 5610
6 cells/ml and
incubated with HBSS (neg ctrl), 20 ng/ml LPS (pos ctrl),
norepinephrine (10
210 M) or epinephrine (10
210 M) for 4 hrs at
37uC/5%CO2. Supernatants were analyzed by ELISA for TNFa,
IL-1b, IL-6 and MIP-2 (all R&D Systems, Minneapolis, MN).
Isolation of total RNA and detection of rat tyrosine-
hydroxylase (TH) and rat dopamine-b-hydroxylase (DBH)
by real-time quantitative PCR analysis
Total RNA was extracted from isolated phagocytes using Trizol
reagent (Life Technologies, Grand Island, NY) according to the
manufacturer’s instructions. Reverse transcription was performed
with 1 mg RNA using Reverse Transcriptase AMV (Roche,
Indianapolis, IN) according to the manufacturer’s instructions.
Real-time quantitative PCR was then performed using SYBRH
Green PCR Master Mix (Applied Biosystems, Foster City, CA).
The following primers were used: rat TH: FOR 59-AGT CTG
GCC TTC CGC GTG TTT CAA-39 and REV 59-GGG CGC
TGG ATA CGA GAG GCA TAG-39; rat DBH FOR: 59-CTG
CGA CCC CAA GGA TTA TG-39 and REV 59-CAG CAC
GTG GCG ACA GTA GTT-39; rat GAPDH: FOR 59-CGG
CAA GTT CAA CGG CAC AGT CA-39 and REV 59-CTT
TCC AGA GGG GCC ATC CAC AG-39. Product sizes were
458 bp (TH), 439 bp (DBH), and 424 bp (GAPDH).
Analysis of cell supernatants for catecholamines
EIA kits for Norepinephrine and Epinephrine were obtained
from Rocky Mountain Diagnostics, Colorado Springs, CO.
Supernatant fluids from phagocytic cells were analyzed according
to the manufacturer’s instructions.
IgG immune complex and LPS-induced alveolitis
Intraperitoneal ketamine (100 mg/kg body weight) (Fort Dodge
Animal Health, Fort Dodge, IA) was used for anesthesia and
intraperitoneal xylazine (13 mg/kg body weight) (Bayer Corp.
Shawnee Mission, KS) for sedation. Induction of IgG immune
complex-induced alveolitis was performed as previously described
[41]. Rats received 2.5 mg of rabbit polyclonal IgG anti-BSA
(ICN Biomedicals, Costa Mesa, CA) in 300 ml of PBS intratra-
cheally, followed by i.v. injection of either 10 mg of BSA in 0.5 ml
PBS (injury) or 0.5 ml PBS (neg ctrl). For LPS-induced alveolitis,
rats received 300 mg of LPS (Sigma Aldrich, St. Louis, MO) in a
total volume of 300 ml PBS intratracheally. Maximum level of
injury in LPS-alveolitis was reached 6 hr after LPS-instillation.
Permeability index was performed as described [41] and
quantified by calculating the amount of radioactivity in lungs
divided by the amount of radioactivity in 1.0 ml blood.
Lung myeloperoxidase content
Whole-lung MPO activity was quantified as previously
described [42].
BAL fluid analysis
BAL fluids were collected by instilling and withdrawing 10 mL
of sterile PBS three times from rat lungs. Cellular contents were
counted by Coulter cytometry after lysis of erythrocytes. Contents
of interleukin IL-6, TNFa, IL-1b and noradrenaline in BAL fluids
were measured using ELISA kits (R&D Systems, Minneapolis,
MN and Rocky Mountain Diagnostics, Colorado Springs, CO,
respectively).
Morphological assessment of lung injury
Rat lungs were fixed by intratracheal instillation of 10 ml
buffered (pH 7.2) formalin (10%). The lungs were further fixed in
a 10% buffered formalin solution for histological examination by
tissue sectioning and staining with H&E.
Figure 8. Severity of IgG-IC ALI following pharmacologic
blockade of mineralocorticoid and glucocorticoid receptors
(by spironolactone and RU 28362, respectively) in adrenal-
intact and ADX animals, as assessed by permeability index. The
a2-adrenergic antagonist RX 821002 was employed in ADX rats. Each
bar represents n$5 rats. Neg ctrl, negative control with intratracheal
instillation of PBS.
doi:10.1371/journal.pone.0004414.g008
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Flushed whole rat lungs were homogenized in ice-cold RIPA
buffer containing a protease-inhibitor cocktail (Roche, Indiana-
polis, IN). After protein extraction, sonication and protein
measurement, samples were separated in a denaturing polyacryl-
amide gel and transferred to a PVDF membrane. After blocking
with 5% milk-TBST washing in TBST, membranes were then
incubated in appropriate primary antibodies (ICAM-1, VCAM-1:
Santa Cruz Biotechnology, Santa Cruz, CA; GAPDH: Abcam,
Cambridge, MA) at 4uC overnight. After washing, membranes
were incubated with the appropriate HRP-conjugated secondary
antibodies (Amersham, Arlington Heights, IL) and analyzed by
ECL development.
Receptor agonists and antagonists
Agonists and antagonists (all Sigma Aldrich, St. Louis, MO)
were administered to rats intraperitoneally in a total volume of
1.5 ml. Following agents were used: 1,2-propanediol (vehicle,
1 ml/kg), RX 821002 (a2-adrenoceptor antagonist, 2.5 mg/kg),
RU 28362 (glucocorticoid receptor antagonist, 150 mg/kg) and
spironolactone (mineralocorticoid receptor antagonist, 50 mg/kg).
RX 821002 and spironolactone were administered immediately
before induction of IC-induced lung injury, while RU 28362 was
administered 1 hr before initiation of lung injury.
Statistical analysis
All values are expressed as means6SEM. Data were analyzed
with a one-way ANOVA and individual group means were then
compared with a Student-Newman-Keuls test. Differences were
considered significant when p#0.05.
Acknowledgments
We are indebted to Lisa Riggs, Robin Kunkel and Roscoe Warner for their
excellent support in the tissue histology studies and illustrations. Further,
we thank Beverly Schumann and Sue Scott for their outstanding assistance
in the preparation of this manuscript.
Author Contributions
Conceived and designed the experiments: MAF MSHL PAW. Performed
the experiments: MAF DR BAN DED AL. Analyzed the data: MAF.
Wrote the paper: MAF JVS PAW.
References
1. Sternberg EM (2006) Neural regulation of innate immunity: a coordinated
nonspecific host response to pathogens. Nat Rev Immunol 6: 318–328.
2. Tracey KJ (2002) The inflammatory reflex. Nature 420: 853–859.
3. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve–an
integrative interface between two supersystems: the brain and the immune
system. Pharmacol Rev 52: 595–638.
4. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al. (2000)
Vagus nerve stimulation attenuates the systemic inflammatory response to
endotoxin. Nature 405: 458–462.
5. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, et al. (2003) Nicotinic
acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.
Nature 421: 384–388.
6. Tracey KJ (2007) Physiology and immunology of the cholinergic antiinflamma-
tory pathway. J Clin Invest 117: 289–296.
7. Flierl MA, Rittirsch D, Huber-Lang M, Sarma JV, Ward PA (2008)
Catecholamines-Crafty Weapons in the Inflammatory Arsenal of Immune/
Inflammatory Cells or Opening Pandora’s Box? Mol Med 14: 195–204.
8. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, et al. (2007) Phagocyte-
derived catecholamines enhance acute inflammatory injury. Nature 449: 721–725.
9. Madden KS, Sanders VM, Felten DL (1995) Catecholamine influences and
sympathetic neural modulation of immune responsiveness. Annu Rev Pharma-
col Toxicol 35: 417–448.
10. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, et al. (2005)
Adrenergic receptors mediate stress-induced elevations in extracellular Hsp72.
J Appl Physiol 99: 1789–1795.
11. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, et al. (2005)
Catecholamines mediate stress-induced increases in peripheral and central
inflammatory cytokines. Neuroscience 135: 1295–1307.
12. Madden KS, Felten SY, Felten DL, Sundaresan PR, Livnat S (1989)
Sympathetic neural modulation of the immune system. I. Depression of T cell
immunity in vivo and vitro following chemical sympathectomy. Brain Behav
Immun 3: 72–89.
13. Maestroni GJ, Mazzola P (2003) Langerhans cells beta 2-adrenoceptors: role in
migration, cytokine production, Th priming and contact hypersensitivity.
J Neuroimmunol 144: 91–99.
14. Benschop RJ, Nieuwenhuis EE, Tromp EA, Godaert GL, Ballieux RE, et al.
(1994) Effects of beta-adrenergic blockade on immunologic and cardiovascular
changes induced by mental stress. Circulation 89: 762–769.
15. Chelmicka-Schorr E, Checinski M, Arnason BG (1988) Chemical sympathec-
tomy augments the severity of experimental allergic encephalomyelitis.
J Neuroimmunol 17: 347–350.
16. Bergquist J, Tarkowski A, Ekman R, Ewing A (1994) Discovery of endogenous
catecholamines in lymphocytes and evidence for catecholamine regulation of
lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A 91:
12912–12916.
17. Kradin R, Rodberg G, Zhao LH, Leary C (2001) Epinephrine yields
translocation of lymphocytes to the lung. Exp Mol Pathol 70: 1–6.
18. Ackerman KD, Madden KS, Livnat S, Felten SY, Felten DL (1991) Neonatal
sympathetic denervation alters the development of in vitro spleen cell
proliferation and differentiation. Brain Behav Immun 5: 235–261.
19. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL (1990)
Stimulation of alpha-adrenergic receptor augments the production of macro-
phage-derived tumor necrosis factor. J Immunol 145: 1430–1434.
20. Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL (1994)
Endogenous norepinephrine regulates tumor necrosis factor-alpha production
from macrophages in vitro. J Immunol 152: 3024–3031.
21. Cosentino M, Marino F, Bombelli R, Ferrari M, Lecchini S, et al. (1999)
Endogenous catecholamine synthesis, metabolism, storage and uptake in human
neutrophils. Life Sci 64: 975–981.
22. Brown SW, Meyers RT, Brennan KM, Rumble JM, Narasimhachari N, et al.
(2003) Catecholamines in a macrophage cell line. J Neuroimmunol 135: 47–55.
23. Morken JJ, Warren KU, Xie Y, Rodriguez JL, Lyte M (2002) Epinephrine as a
mediator of pulmonary neutrophil sequestration. Shock 18: 46–50.
24. Faraj BA, Olkowski ZL, Jackson RT (1991) Binding of [3H]-dopamine to
human lymphocytes: possible relationship to neurotransmitter uptake sites.
Pharmacology 42: 135–141.
25. Faraj BA, Olkowski ZL, Jackson RT (1995) A cocaine-sensitive active dopamine
transport in human lymphocytes. Biochem Pharmacol 50: 1007–1014.
26. Marino F, Cosentino M, Bombelli R, Ferrari M, Lecchini S, et al. (1999)
Endogenous catecholamine synthesis, metabolism storage, and uptake in human
peripheral blood mononuclear cells. Exp Hematol 27: 489–495.
27. Gordon J, Barnes NM (2003) Lymphocytes transport serotonin and dopamine:
agony or ecstasy? Trends Immunol 24: 438–443.
28. Bergquist J, Josefsson E, Tarkowski A, Ekman R, Ewing A (1997) Measurements
of catecholamine-mediated apoptosis of immunocompetent cells by capillary
electrophoresis. Electrophoresis 18: 1760–1766.
29. Buu NT (1993) Uptake of 1-methyl-4-phenylpyridinium and dopamine in the
mouse brain cell nuclei. J Neurochem 61: 1557–1560.
30. Josefsson E, Bergquist J, Ekman R, Tarkowski A (1996) Catecholamines are
synthesized by mouse lymphocytes and regulate function of these cells by
induction of apoptosis. Immunology 88: 140–146.
31. Saha B, Mondal AC, Majumder J, Basu S, Dasgupta PS (2001) Physiological
concentrations of dopamine inhibit the proliferation and cytotoxicity of human
CD4+ and CD8+ T cells in vitro: a receptor-mediated mechanism.
Neuroimmunomodulation 9: 23–33.
32. Lentsch AB, Shanley TP, Sarma V, Ward PA (1997) In vivo suppression of NF-
kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-
13. J Clin Invest 100: 2443–2448.
33. Johnson KJ, Ward PA (1974) Acute immunologic pulmonary alveolitis. J Clin
Invest 54: 349–357.
34. Lentsch AB, Ward PA (2001) Regulation of experimental lung inflammation.
Respir Physiol 128: 17–22.
35. Mulligan MS, Schmid E, Beck-Schimmer B, Till GO, Friedl HP, et al. (1996)
Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin
Invest 98: 503–512.
36. Ward PA (1996) Rous-Whipple Award Lecture. Role of complement in lung
inflammatory injury. Am J Pathol 149: 1081–1086.
37. Ozturk H, Ozturk H, Gedik S, Uzunlar AK, Ketani A (2007) Effects of specific
inhibition of cyclooxygenease-2 on kidney in bilateral adrenalectomized rats. Int
Urol Nephrol 39: 267–270.
38. Weinberg PF, Matthay MA, Webster RO, Roskos KV, Goldstein IM, et al.
(1984) Biologically active products of complement and acute lung injury in
patients with the sepsis syndrome. Am Rev Respir Dis 130: 791–796.
39. MacKenzie SM, Clark CJ, Fraser R, Gomez-Sanchez CE, Connell JM, et al.
(2000) Expression of 11beta-hydroxylase and aldosterone synthase genes in the
rat brain. J Mol Endocrinol 24: 321–328.
Catecholamines & Inflammation
PLoS ONE | www.plosone.org 10 February 2009 | Volume 4 | Issue 2 | e441440. Rudolph AE, Blasi ER, Delyani JA (2000) Tissue-specific corticosteroidogenesis
in the rat. Mol Cell Endocrinol 165: 221–224.
41. Czermak BJ, Lentsch AB, Bless NM, Schmal H, Friedl HP, et al. (1999)
Synergistic enhancement of chemokine generation and lung injury by C5a or the
membrane attack complex of complement. Am J Pathol 154: 1513–1524.
42. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T (1983) Assay method for
myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 132:
345–352.
Catecholamines & Inflammation
PLoS ONE | www.plosone.org 11 February 2009 | Volume 4 | Issue 2 | e4414